PERSIST (PERsister-State In-Silico Targeting): residual-state modelling of single-cell drug response for combination therapy prediction in EGFR-mutant NSCLC and TNBC
drug-repurposing single-cell-rna-seq nsclc connectivity-map combination-therapy computational-oncology lincs-l1000 drug-tolerant-persister
-
Updated
Aug 1, 2026 - R